News From The Journal Of Clinical Investigation: March 26, 2012
 

ONCOLOGY Promise of new treatment options for chemotherapy-resistant breast cancers p53 is lost or functionally impaired in many human cancers, and its absence is often associated with a poor response to conventional chemotherapy. Thus, much effort is currently devoted to developing novel treatments for p53-deficient malignancies...

More...